Entheon Biomedical (XCNQ:ENBI) Total Assets : C$0.40 Mil (As of Nov. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Total Assets?

Entheon Biomedical's Total Assets for the quarter that ended in Nov. 2023 was C$0.40 Mil.

During the past 12 months, Entheon Biomedical's average Total Assets Growth Rate was -37.10% per year. During the past 3 years, the average Total Assets Growth Rate was -54.40% per year. During the past 5 years, the average Total Assets Growth Rate was -24.70% per year.

During the past 7 years, Entheon Biomedical's highest 3-Year average Total Assets Growth Rate was 232.90%. The lowest was -54.40%. And the median was 47.80%.

Total Assets is connected with ROA %. Entheon Biomedical's annualized ROA % for the quarter that ended in Nov. 2023 was -71.15%. Total Assets is also linked to Revenue through Asset Turnover. Entheon Biomedical's Asset Turnover for the quarter that ended in Nov. 2023 was 0.00.

Entheon Biomedical Total Assets Historical Data

The historical data trend for Entheon Biomedical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Total Assets Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Total Assets

Get a 7-Day Free Trial

1.84

1.72

9.98

0.77

0.40

Entheon Biomedical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Total Assets	Get a 7-Day Free Trial															0.77	0.67	0.57	0.43	0.40

Entheon Biomedical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Entheon Biomedical's Total Assets for the fiscal year that ended in Nov. 2023 is calculated as

Total Assets	=	Total Equity (A: Nov. 2023 )	+	Total Liabilities (A: Nov. 2023 )
	=	0.316	+	0.085
	=	0.40

Entheon Biomedical's Total Assets for the quarter that ended in Nov. 2023 is calculated as

Total Assets	=	Total Equity (Q: Nov. 2023 )	+	Total Liabilities (Q: Nov. 2023 )
	=	0.316	+	0.085
	=	0.40

Entheon Biomedical (XCNQ:ENBI) Total Assets Explanation

Total Assets is connected with ROA %.

Entheon Biomedical's annualized ROA % for the quarter that ended in Nov. 2023 is

ROA %	=	Net Income (Q: Nov. 2023 )	/	( (Total Assets (Q: Aug. 2023 )	+	Total Assets (Q: Nov. 2023 ))	/ count )
	=	-0.296	/	( (0.431	+	0.401)	/ 2 )
	=	-0.296	/	0.416
	=	-71.15 %

Note: The Net Income data used here is four times the quarterly (Nov. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Entheon Biomedical's Asset Turnover for the quarter that ended in Nov. 2023 is

	Asset Turnover
=	Revenue (Q: Nov. 2023 )	/	( (Total Assets (Q: Aug. 2023 )	+	Total Assets (Q: Nov. 2023 ))	/ count )
=	0	/	( (0.431	+	0.401)	/ 2 )
=	0	/	0.416
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Entheon Biomedical Total Assets Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines